Benitec Biopharma (BNTC) Leases (2019 - 2025)
Benitec Biopharma (BNTC) has disclosed Leases for 7 consecutive years, with $964000.0 as the latest value for Q1 2025.
- Quarterly Leases rose 187.76% to $964000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $964000.0 through Mar 2025, up 187.76% year-over-year, with the annual reading at $270000.0 for FY2024, 48.67% down from the prior year.
- Leases hit $964000.0 in Q1 2025 for Benitec Biopharma, up from $137000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $964000.0 in Q1 2025 to a low of $137000.0 in Q4 2024.
- Historically, Leases has averaged $570941.2 across 5 years, with a median of $589000.0 in 2023.
- Biggest five-year swings in Leases: skyrocketed 228.57% in 2022 and later crashed 65.75% in 2024.
- Year by year, Leases stood at $888000.0 in 2021, then fell by 26.8% to $650000.0 in 2022, then plummeted by 38.46% to $400000.0 in 2023, then plummeted by 65.75% to $137000.0 in 2024, then soared by 603.65% to $964000.0 in 2025.
- Business Quant data shows Leases for BNTC at $964000.0 in Q1 2025, $137000.0 in Q4 2024, and $204000.0 in Q3 2024.